CTLA4 and breast carcinoma: In addition, downregulation of genes related to the Th1 pathway and antigen presentation was observed in association with the higher expression of CTLA-4, supporting the hypothesis that CTLA-4 may be associated with an impairment of antigen presentation, leading to an inhibition of Th1 and CTL activation, as previously reported in breast cancer [68].